Saudi market index closes

TASI
10,326.47
+18.10 (+0.18%)
MT30
1,400.46
+2.64 (+0.19%)
NOMU (Capped)
22,054.14
+105.57 (+0.48%)
Sukuk
890.39
-0.62 (-0.07%)

Source: Saudi Exchange data supplied for this session. Not live prices.

GoFinsa

Welcome to GoFinsa!

BUPA ARABIA

8210

GoFinsa Saudi Stock Investment Strength Index

81%
Investment strength
Explore the GoFinsa Saudi Stocks Index →

Analytical index, not a guaranteed return or buy recommendation.

145 SAR
Change: +1 SARChange %: +0.69 %Trading volume: 177,952 sharesTrades: 1,878 Open: 144 SARHigh: 145.4 SARLow: 142.6 SAR
Last available trade from session · 2026-11-12

BUPA ARABIA stock (8210) price and technical analysis

GoFinsa tracks BUPA ARABIA under symbol 8210, with the latest available price at 145 SAR. This page includes multi-timeframe charts, technical analysis and related market news.

Market data source: بيانات جلسة السوق السعودي المقدمة من المستخدم · Latest available update: 2026-11-12 · Delayed market data

Bupa Arabia: Business Model, Financial Analysis and Investment Risks

Independent educational company research about the existing Saudi-listed instrument. This content does not constitute a real-time price quote, investment recommendation or a promise of future results.

What the company actually does

Bupa Arabia is associated with التأمين الصحي وإدارة تغطيات العلاج للمؤسسات والأفراد. These activities have different operating requirements and therefore different paths from revenue to profitability. Before analysing the shares, an investor should identify which of these activities contributes the most to cash generation and which requires continuing investment. The distinction matters because expanding reported sales in a capital-intensive segment can consume cash before it creates returns. Company presentations and audited statements provide the basis for confirming the current business mix. Historical descriptions should be reconciled with recent acquisitions, disposals and segment reorganisations rather than being treated as permanent facts.

Revenue drivers that deserve separate attention

For Bupa Arabia, relevant drivers include الأقساط المكتتبة والإيرادات التأمينية بعد احتساب التزامات المطالبات والتكاليف. An increase in market demand may support sales, but volumes, pricing and the contract or product mix determine how much of that demand translates into company revenue. Investors should ask whether improvement arises from recurring customers, temporary pricing, a one-time agreement or expansion that has not yet reached steady-state economics. Where segment figures are available, revenue should be compared with the costs directly attributable to the activity. Forecasts should remain conditional on reliable evidence and should not be presented as company guidance unless the issuer actually made them.

Assets and operating investment

An assessment of Bupa Arabia should account for المستشفيات ومقدمو الرعاية، التسعير الاكتواري، احتياطات المطالبات وإعادة التأمين. These commitments can create a difference between accounting earnings and free cash generation, especially when expansion happens ahead of demand. Capital expenditure might increase productive capacity or service quality without automatically raising utilization. Investors should compare plans with actual execution, examine maintenance needs and identify which costs are recurring. An investment can be strategically attractive but financially disappointing if its return falls below its funding and operating costs. The detailed amounts require current company disclosures rather than assumptions.

Measures of operating progress

A useful monitoring framework for Bupa Arabia includes نسبة المطالبات، مصروفات الاكتتاب، نمو المؤمن عليهم، وجودة التحصيل. These variables should be tracked alongside financial statements rather than as isolated statistics. A positive movement in a single metric can conceal higher costs, declining profitability elsewhere or an increased burden on working capital. The best comparison uses consistent definitions and reporting periods, with explicit notes about acquisitions, exceptional items and seasonality. If a data point is unavailable, record it as unavailable instead of inventing an estimate or treating an old observation as current.

Business model and revenue quality

The investment case for Bupa Arabia begins with an understanding of التأمين الصحي وإدارة تغطيات العلاج للمؤسسات والأفراد. A company can report sales growth without creating an equal increase in economic value if its mix moves toward low-margin products, costs are deferred or exceptional items affect the reported period. Investors should separate recurring customer demand from one-time contracts and distinguish price changes from growth in service volumes. Segment disclosure, when available, provides a more useful basis for evaluation than a single consolidated sales figure. Published company reports should be the source for any precise growth rate.

Operating economics and margin sensitivity

Margins depend on factors including الأقساط المكتتبة والإيرادات التأمينية بعد احتساب التزامات المطالبات والتكاليف. An improvement in headline revenue can coincide with pressure on gross or operating profit if input prices, staff expenses or maintenance costs rise faster than activity. It is therefore useful to compare several reporting periods and examine the components of costs instead of assuming that scale always produces operating leverage. Depreciation, impairment, provisions and other noncash items may also influence reported earnings, but cash commitments eventually determine the ability to maintain assets and service obligations. The mix of revenue streams can explain why peers with similar sales growth have different profit outcomes.

Balance sheet, funding and cash generation

The financing requirements of Bupa Arabia should be studied in light of المستشفيات ومقدمو الرعاية، التسعير الاكتواري، احتياطات المطالبات وإعادة التأمين. Net income is an accounting measure and should not be mistaken for immediately distributable cash. Working capital can absorb liquidity as receivables, inventories or contractual commitments rise, even when reported profit improves. Equally, temporary cash inflows can distort one reporting period. Analysts should compare operating cash flow with maintenance and expansion expenditure, debt payments and any relevant regulatory capital requirements. Specific balances should be taken from dated filings; this analysis intentionally avoids inventing current figures.

Competitive position and execution

A durable competitive position is not demonstrated merely by the size of the addressable market. For Bupa Arabia, important evidence comes from execution in التأمين الصحي وإدارة تغطيات العلاج للمؤسسات والأفراد, the economics of customer acquisition, reliability of service and the cost required to preserve market position. Management initiatives and expansion announcements should be treated as plans until the associated operational or financial benefits are demonstrated. Competitors may respond with pricing, increased capacity or different distribution models. An investor should ask which advantage is measurable, how much it costs to maintain and how quickly it could weaken.

Sector-specific investment risks

The key analytical variables include نسبة المطالبات، مصروفات الاكتتاب، نمو المؤمن عليهم، وجودة التحصيل. Movements in any one indicator may be misleading without context from others. For example, higher demand does not guarantee improved cash flow when working capital, input costs or financing requirements also expand. Regulation, contracts, supply interruptions and macroeconomic changes may cause results to diverge from expectations. A balanced assessment weighs plausible adverse scenarios as well as favorable ones, rather than converting a general sector trend into a prediction about the share price.

Quarterly monitoring process

A practical monitoring sheet for Bupa Arabia should record نسبة المطالبات، مصروفات الاكتتاب، نمو المؤمن عليهم، وجودة التحصيل, along with segment revenue, operating profit, operating cash flow and major announced financing or investment decisions. Compare consistent periods and record significant one-off events or changes in accounting treatment. If management supplies guidance, distinguish that forward-looking statement from an independently verified result. Use issuer reports, the Saudi Exchange and official regulatory filings for company-specific numerical claims. Commentary from market websites may be useful context, but it should not substitute for the source filing.

Valuation discipline and shareholder outcomes

Valuation depends on the cash that can reasonably accrue to shareholders after operating needs, capital expenditure and financial obligations. Trading multiples can assist a comparison when profits are stable and accounting definitions match; they become less informative when a company has exceptional charges, rapidly changing operations or structurally different peers. The relevant price must be dated and the share count updated for corporate actions. An apparently attractive valuation does not remove business risk, and a strong company may still offer poor prospective returns when purchased at an excessive price. This material is educational, not personalized investment advice.

For financial figures and company-specific announcements, refer to the issuer's official reports and Saudi Exchange disclosures.

Saudi Exchange — official company disclosures

Frequently asked questions about BUPA ARABIA (8210)

What is the price of BUPA ARABIA (8210)?

The latest price available in GoFinsa data is 145 SAR. Price status may be live or delayed depending on the market and data provider.

What does the technical analysis for BUPA ARABIA (8210) show?

There is currently insufficient data to produce technical analysis for this instrument.

What is the GoFinsa.com General Index for BUPA ARABIA?

The GoFinsa.com General Index is currently unavailable for this instrument.